CRS Stock Recent News

CRS LATEST HEADLINES

CRS Stock News Image - zacks.com

CRS, SHAK and FJTSY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 17, 2025.

zacks.com 2025 Jun 17
CRS Stock News Image - fxempire.com

Specialty metals maker Carpenter Technology, Inc. (CRS) is up 914% since its first Outlier signal in 2005.

fxempire.com 2025 Jun 13
CRS Stock News Image - zacks.com

Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.

zacks.com 2025 Jun 11
CRS Stock News Image - zacks.com

CRS hits a 52-week high as record operating income, soaring aerospace demand and a raised FY25 guidance boost investor optimism.

zacks.com 2025 Jun 09
CRS Stock News Image - zacks.com

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.

zacks.com 2025 Jun 04
CRS Stock News Image - zacks.com

Here is how Carpenter Technology (CRS) and Aris Mining Corporation (ARMN) have performed compared to their sector so far this year.

zacks.com 2025 Jun 02
CRS Stock News Image - globenewswire.com

WATERTOWN, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic rhinosinusitis (CRS), today announced positive results from the ENLIGHTEN 2 Phase 3 clinical trial of LYR-210 in adult patients with CRS. The ENLIGHTEN 2 trial met its primary endpoint, with LYR-210 demonstrating statistically significant improvement compared to sham control in a composite of the three cardinal symptoms (3CS) of CRS (nasal obstruction, nasal discharge, facial pain/pressure) at week 24 (-1.13; p=0.0078) in patients without nasal polyps.

globenewswire.com 2025 Jun 02
CRS Stock News Image - zacks.com

Here is how Carpenter Technology (CRS) and Aris Mining Corporation (ARMN) have performed compared to their sector so far this year.

zacks.com 2025 May 16
CRS Stock News Image - zacks.com

Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ODD, CRS, HRTG, APH, MRX.

zacks.com 2025 May 09
CRS Stock News Image - globenewswire.com

– Phase 3 results from ENLIGHTEN 2 pivotal Phase 3 trial of LYR 210 in Chronic Rhinosinusitis (CRS) expected in Q2 2025 – – Phase 3 results from ENLIGHTEN 2 pivotal Phase 3 trial of LYR 210 in Chronic Rhinosinusitis (CRS) expected in Q2 2025 –

globenewswire.com 2025 May 06
10 of 50